Science Explorer Back to mapMap

Most cited papers from Orion Corporation (Finland)

What are the most cited papers from Orion Corporation (Finland)?

The most cited paper from Orion Corporation (Finland) is "Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial" (Ferenc Folláth, JGF Cleland, Hanjörg Just et al., 2002), with 1,186 citations. Next come "Kinetics of Human Soluble and Membrane-Bound Catechol O-Methyltransferase: A Revised Mechanism and Description of the Thermolabile Variant of the Enzyme" (1,173) and "Advances in TRP channel drug discovery: from target validation to clinical studies" (550).

Showing 50 of 62 papers. Every paper with more than 164 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial Ferenc Folláth, JGF Cleland, Hanjörg Just et al. · The Lancet Jul 2002 1,186
2 Kinetics of Human Soluble and Membrane-Bound Catechol O-Methyltransferase: A Revised Mechanism and Description of the Thermolabile Variant of the Enzyme Timo I. Lotta, Jukka Vidgren, Carola Tilgmann et al. · Biochemistry 4 Apr 1995 1,173
3 Advances in TRP channel drug discovery: from target validation to clinical studies Ari Koivisto, Maria Gabriela Belvisi, Rachelle Gaudet et al. · Nature Reviews Drug Discovery ReviewOpen access 15 Sep 2021 550
4 Factors predictive of the development of Levodopa‐induced dyskinesia and wearing‐off in Parkinson's disease C. Warren Olanow, Karl D. Kieburtz, Olivier Rascol et al. · Movement Disorders 29 Apr 2013 484
5 Spring viremia of carp (SVC) Winfried Ahne, HV Björklund, Sandra Simone Essbauer et al. · Diseases of Aquatic Organisms Open access 2002 448
6 Crystal structure of catechol O-methyltransferase Jukka Vidgren, L. Anders Svensson, Anders Liljas · Nature Mar 1994 441
7 Effect of Levosimendan on the Short-Term Clinical Course of Patients With Acutely Decompensated Heart Failure Milton Packer, Wilson S. Colucci, Lloyd D. Fisher et al. · JACC Heart Failure Open access Apr 2013 439
8 Interstitial Chemotherapy with Carmustine-loaded Polymers for High-grade Gliomas: A Randomized Double-blind Study Simo Valtonen, UI la Timonen, Petri Toivanen et al. · Neurosurgery Jul 1997 428
9 FusionCatcher – a tool for finding somatic fusion genes in paired-end RNA-sequencing data Daniel Nicorici, Mihaela Şatalan, Henrik Edgren et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 19 Nov 2014 413
10 Dopaminergic neuronal loss and motor deficits in Caenorhabditis elegans overexpressing human α‐synuclein Merja Lakso, Suvi Vartiainen, Anu‐Maarit Moilanen et al. · Journal of Neurochemistry 13 Jun 2003 401
11 A primer-guided nucleotide incorporation assay in the genotyping of apolipoprotein E Ann‐Christine Syvänen, Katriina Aalto‐Setälä, LEENA M. HARJU et al. · Genomics Dec 1990 391
12 Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure Markku S. Nieminen, Juha Akkila, Gerd P Hasenfuss et al. · Journal of the American College of Cardiology Open access Nov 2000 387
13 Discovery of ODM-201, a new-generation androgen receptor inhibitor targeting resistance mechanisms to androgen signaling-directed prostate cancer therapies Anu‐Maarit Moilanen, Reetta Riikonen, Riikka Oksala et al. · Scientific Reports Open access 3 Jul 2015 379
14 Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide Karim S. Fizazi, Neal D. Shore, Teuvo L.J. Tammela et al. · New England Journal of Medicine Open access 9 Sep 2020 371
15 Lactobacilli and Streptococci Induce Interleukin-12 (IL-12), IL-18, and Gamma Interferon Production in Human Peripheral Blood Mononuclear Cells Minja Miettinen, Sampsa Matikainen, Jaana Vuopio‐Varkila et al. · Infection and Immunity Open access Dec 1998 343
16 Genomic organization of the human catechol O‐methyltransferase gene and its expression from two distinct promoters Jukka Tenhunen, Marjo Salminen, Kenneth H. Lundstrom et al. · European Journal of Biochemistry Open access Aug 1994 335
17 Comparison of Hepatic 2D Sandwich Cultures and 3D Spheroids for Long-term Toxicity Applications: A Multicenter Study Catherine C. Bell et al. · Toxicological Sciences Open access 8 Jan 2018 330
18 Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure Maria Nikolaou, John Parissis, Mehmet Birhan Yılmaz et al. · European Heart Journal Open access 22 Oct 2012 329
19 Effect ofLactobacillusGG Yoghurt in Prevention of Antibiotic Associated Diarrhoea Simo Siitonen, Heikki Vapaatalo, Seppo Salminen et al. · Annals of Medicine 1990 329
20 Levosimendan: Molecular mechanisms and clinical implications Zoltán Papp et al. · International Journal of Cardiology 26 Jul 2011 320
21 Impact of gastrointestinal physiology on drug absorption in special populations––An UNGAP review Cordula Stillhart, Katarina M. Vučićević, Patrick Augustijns et al. · European Journal of Pharmaceutical Sciences Open access 25 Feb 2020 315
22 Microemulsions for topical delivery of estradiol Sari Peltola, Paula Saarinen‐Savolainen, Juha Kiesvaara et al. · International Journal of Pharmaceutics Mar 2003 315
23 Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan Heimo Haikala · Journal of Molecular and Cellular Cardiology Sep 1995 312
24 Postoperative Pharmacokinetics and Sympatholytic Effects of Dexmedetomidine Pekka O. Talke, Charles A. Richardson, Mika Scheinin et al. · Anesthesia & Analgesia Nov 1997 303
25 Bioavailability of dexmedetomidine after extravascular doses in healthy subjects Markku I. Anttila, Jani Penttilä, Antti V. Helminen et al. · British Journal of Clinical Pharmacology Open access 29 Aug 2003 303
26 Towards Better Definition, Quantification and Treatment of Fibrosis in Heart Failure. A Scientific Roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology Rudolf A. de Boer et al. · European Journal of Heart Failure Open access 4 Feb 2019 301
27 Clinical effects and pharmacokinetics of medetomidine and its enantiomers in dogs Kuusela, Marja Riitta Raekallio, Anttila et al. · Journal of Veterinary Pharmacology and Therapeutics Feb 2000 299
28 Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life Terhi M Kilpi, Elja Herva, Tarja Kaijalainen et al. · The Pediatric Infectious Disease Journal Jul 2001 298
29 Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture Anna Lahti, Ville J. Kujala, Hugh Chapman et al. · Disease Models & Mechanisms Open access 4 Nov 2011 291
30 Glucose oxidase from Aspergillus niger: the mechanism of action with molecular oxygen, quinones, and one-electron acceptors Vladimir Leskovac, Svetlana Trivić, Gerd Wohlfahrt et al. · The International Journal of Biochemistry & Cell Biology 17 Dec 2004 273
31 DEXMEDETOMIDINE ATTENUATES SYMPATHOADRENAL RESPONSES TO TRACHEAL INTUBATION AND REDUCES THE NEED FOR THIOPENTONE AND PEROPERATIVE FENTANYL B. Scheinin, Leena Lindgren, Tabitha Randell et al. · British Journal of Anaesthesia Open access Feb 1992 271
32 Sustained Hemodynamic Effects of Intravenous Levosimendan Matti Kivikko, Lasse Lehtonen, Wilson S. Colucci · Circulation 6 Jan 2003 258
33 Interaction of liposomes with human skin in vitro — The influence of lipid composition and structure Merja Kirjavainen, Arto O. Urtti, Ilpo Jääskeläinen et al. · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism Dec 1996 254
34 Silica xerogel as an implantable carrier for controlled drug delivery—evaluation of drug distribution and tissue effects after implantation Pirjo Kortesuo, Manja Ahola, Stefan Karlsson et al. · Biomaterials 2000 254
35 The evolving role of investigative toxicology in the pharmaceutical industry François Pognan, Mario Beilmann, Harrie C. M. Boonen et al. · Nature Reviews Drug Discovery ReviewOpen access 13 Feb 2023 253
36 Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models Richard John Weaver et al. · Nature Reviews Drug Discovery ReviewOpen access 20 Nov 2019 252
37 Metabolomic Profiling of Extracellular Vesicles and Alternative Normalization Methods Reveal Enriched Metabolites and Strategies to Study Prostate Cancer-Related Changes Maija Puhka, Maarit S. Takatalo, Maria-Elisa Nordberg et al. · Theranostics Open access 2017 237
38 Dexmedetomidine versus propofol/midazolam for long-term sedation during mechanical ventilation Esko Ruokonen, Ilkka Parviainen, Stephan Matthias Jakob et al. · Intensive Care Medicine Open access 15 Sep 2008 234
39 Binding of a new Ca2+ sensitizer, levosimendan, to recombinant human cardiac troponin C. A molecular modelling, fluorescence probe, and proton nuclear magnetic resonance study. Piero Pollesello, Martti Ovaska, Juha Kaivola et al. · Journal of Biological Chemistry Open access Nov 1994 234
40 Darolutamide Plus Androgen-Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase III ARASENS Trial Maha Hussain, Bertrand F. TOMBAL, Fred Saad et al. · Journal of Clinical Oncology Open access 16 Feb 2023 230
41 Troponin C–Mediated Calcium Sensitization Induced by Levosimendan Does Not Impair Relaxation Heimo Haikala, Erkki Nissinen, Ehsan Etemadzadeh et al. · Journal of Cardiovascular Pharmacology May 1995 227
42 Nanosuspensions of poorly soluble drugs: Preparation and development by wet milling Peng Liu, Xinyu Rong, Johanna Laru et al. · International Journal of Pharmaceutics 14 Apr 2011 226
43 Adrenergic α2C-Receptors Modulate the Acoustic Startle Reflex, Prepulse Inhibition, and Aggression in Mice Jukka Sallinen, Antti Haapalinna, Timo Viitamaa et al. · Journal of Neuroscience Open access 15 Apr 1998 215
44 Efficacy and safety of entacapone in Parkinson's disease patients with suboptimal Levodopa response: a 6-month randomized placebo-controlled double-blind study in Germany and Austria (Celomen study) Werner H Poewe, Günther Deuschl, A. Gordin et al. · Acta Neurologica Scandinavica Apr 2002 211
45 Pharmacokinetics of levosimendan and its metabolites during and after a 24-hour continuous infusion in patients with severe heart failure Matti Kivikko, Saila Antila, Jaan Eha et al. · International Journal of Clinical Pharmacology and Therapeutics Oct 2002 198
46 Immunoturbidimetric determination of apolipoproteins A-1 and B in serum Pekka Riepponen, Jukka Marniemi, Tapio Rautaoja · Scandinavian Journal of Clinical and Laboratory Investigation 1987 198
47 Activity and safety of ODM-201 in patients with progressive metastatic castration-resistant prostate cancer (ARADES): an open-label phase 1 dose-escalation and randomised phase 2 dose expansion trial Karim S. Fizazi, Christophe Massard, Petri Bono et al. · The Lancet Oncology Open access 25 Jun 2014 196
48 Apoptosis in Toremifene-Induced Growth Inhibition of Human Breast Cancer Cells In Vivo and In Vitro Anni M. Wärri, Riikka Huovinen, Antti Laine et al. · JNCI Journal of the National Cancer Institute Sep 1993 195
49 Neurological complications of drug abuse: pathophysiological mechanisms Jack Neiman, H. M. Haapaniemi, Matti Hillbom · European Journal of Neurology Dec 2000 192
50 Competitive exclusion in poultry––30 years of research Carita Schneitz · Food Control 5 Aug 2004 187

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.